Is retatrutide legal to possess in Spain?

The medicines law's sanctions target manufacturing, importing, distributing and selling; no provision sanctions a private individual's mere possession for personal use. There is, however, no legal route to acquire it: it cannot be marketed, imported by post, or sold online.

Can medicines be bought online in Spain?

Only non-prescription medicines, from registered pharmacies. Spain prohibits online sale of prescription medicines entirely, and its agency restated in 2025 that GLP-1 medicines cannot be sold over the internet in Spain at all.

GLP1 Europe › Legality › Spain

Is retatrutide legal in Spain?

Q: What was Spain's biggest GLP-1 enforcement case?

In June 2025 police and customs dismantled a network illegally commercialising semaglutide: 33 arrests across five provinces, more than 300,000 doses seized worth around two million euros, with charges including offences against public health and money laundering.

Last checked 14 August 2026 · About 7 minutes to read · Sources listed at the end

Short answer

Marketing it is a very serious infringement with fines up to a million euros, and criminal exposure where health is endangered. There is no personal postal import route. Possession itself is not sanctioned.

Spain also produced the largest documented enforcement action in this market: a 2025 operation against an illegal semaglutide network with 33 arrests and over 300,000 doses seized.

Read this first

This page describes published law and documented enforcement, on the date shown above. It is not legal advice, it can lag changes, and how the law applies to a specific person is a question for a lawyer in this country. Retatrutide itself has no marketing authorisation anywhere in the world, so everything here concerns an unauthorised medicine.

What the law says

Spain's medicines law states it directly: no industrially manufactured medicine may be placed on the market without prior authorisation. Manufacturing, importing, dispensing or distributing medicines without the required authorisation is a serious infringement, fined between 30,001 and 90,000 euros. Placing an unauthorised medicine on the market, or marketing a product presented as a medicine without legal recognition as one, is a very serious infringement, fined between 90,001 and one million euros, extendable to five times the value of the products. Separately, the criminal code punishes manufacturing, importing, supplying or marketing unauthorised medicines with six months to three years in prison where a risk to life or health is created.

Note what that second infringement covers: products presented as medicines without being legally recognised. That is the provision that reaches RUO-labelled peptides sold with health claims, the presentation alone completes it.

Possession

Neither the medicines law's infringement catalogue nor the relevant criminal code articles sanction a private individual's mere possession for personal use. The sanctions aim at manufacture, import, distribution and sale.

Importing for personal use

Travellers may carry personal medication matching their prescribed treatment, up to roughly three months' worth, under the medicines agency's foreign-trade rules. Those rules provide no personal postal route, and medicine imports pass systematic pharmaceutical border control. Spain also prohibits online sale of prescription medicines outright, and its agency restated in September 2025 that GLP-1 medicines cannot be sold over the internet in Spain at all. An unauthorised drug arriving by post has no compliant path.

What enforcement actually looks like

In June 2025, national police and customs dismantled an organisation illegally commercialising semaglutide: 33 arrests across five provinces, more than 300,000 doses seized with a market value around two million euros, distribution running through parcel services, and charges including offences against public health and money laundering. The investigation began with a tip from Munich prosecutors, a reminder that these cases cross borders. Documented action targets networks and sellers; we found no sanction of an individual buyer.

Does a "research use only" label change anything?

No. Spanish law carries the same presentation-and-function definition of a medicine as EU law, and its infringement for marketing products presented as medicines makes the label if anything counterproductive for a seller, since selling a "research" peptide with weight-loss framing is precisely the conduct described. The label's full legal position is here.

Common questions

Can I order it from another EU country to Spain?: No route exists for an unauthorised medicine. Spain permits no online sale of prescription medicines even from Spanish pharmacies, and the personal import framework covers carried medication for your own treatment, not postal orders of unapproved drugs.
What happened in the 2025 operation?: A criminal network selling semaglutide illegally was dismantled: 33 arrests in Madrid, Málaga, Alicante, Barcelona and Seville, over 300,000 doses seized, around 400,000 euros in cash. It remains the largest documented action against illegal GLP-1 supply in Europe.
Has Spain named retatrutide in an alert?: Not that we could verify. The Spanish agency republished the Europe-wide GLP-1 warning of September 2025, which names semaglutide, liraglutide and tirzepatide. Retatrutide's unauthorised status follows from the general law rather than a named alert.

Sources

Real Decreto Legislativo 1/2015, articles 2, 9.1, 111 and 114, consolidated text at boe.es, checked 14 August 2026.
Código Penal, article 361.
AEMPS, Circular 1/2025 on foreign trade in medicines, chapter VIII on travellers.
Ministry of the Interior and Agencia Tributaria, dismantling of an illegal semaglutide commercialisation network, 27 June 2025.
AEMPS, republication of the EMA and HMA warning on illegal GLP-1 medicines, 3 September 2025.

Not legal advice. Laws and enforcement practice change, and individual circumstances differ. For a decision that affects you, consult a lawyer qualified in Spain.